Back

Reduced thiazide diuretic use in hfref patients taking sacubitril/valsartan (arni)

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2018

About the speaker

Photo
Ms Tara Mannion

Tallaght University Hospital, Dublin (Ireland)

61 More presentations in this session

Presentation thumbnail
Doctor C. Kapelios (Athens, GR)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Presentation thumbnail
Mrs C. Ariano (Naples, IT)
Abstract
Presentation thumbnail
Professor P. Rossignol (Monaco, MC)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF
12 May 2024
thumbnail
Congress Presentation
Predictors related to ARNI titling in patients cared for in a specialized heart failure unit.
29 June 2021
thumbnail
Congress Session
Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation
18 May 2025
thumbnail
Congress Session
Clinical case discussion: the value of optimising RAAS inhibition and preserving normokalemia in heart failure
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources